Statin-aspirin heart benefits are confirmed
The benefits of combined use of a statin and aspirin in the secondary prevention of cardiovascular disease have been confirmed by a meta-analysis.
The US analysis, covering five randomised trials of secondary prevention, found add- ing pravastatin (40mg/day) to the use of aspirin alone brought about a 31 per cent relative risk reduction for fatal or non-fatal heart attack (Archives of Internal Medicine, January 12).
Combined aspirin-statin therapy was also 26 per cent more effective at preventing MI than statin alone.
Dr John Pittard, a GP in Staines, Middlesex, who help-ed draw up the CHD national service framework, said UK GPs already made widespread use of combination therapy.